Popular Articles
Stretch Mark Remedies

Boston Scientific's Urology/Gynecology Products Featured In Studies At International Urogynecological Association Annual Meeting
Boston Scientific Corporation (NYSE: BSX) announced that results from nine studies involving the Company"s Urology/Gynecology products will be presented at the 34th Annual Meeting of the International Urogynecological Association (IUGA). Presentations will feature Boston Scientific"s pelvic floor reconstruction systems and mid-urethral sling systems used to treat pelvic floor prolapse and stress urinary incontinence (SUI). The Company will also sponsor a symposium highlighting long-term registry data comparing the benefits of experienced-based versus evidence-based outcomes for patients treated with mid-urethral slings. The IUGA Congress will be held June 16-20 at the Villa Erba Conference Center in Como, Italy.
generic viagra online
Daily Alcohol Intake Can Lead To Binge Drinking
Sipping wine, beer or spirits three to four times per week increases the risk of binge drinking, particularly among young men, according to a new study published in the journal Addiction. Researchers from the Universitçİ de Montrçİal and the University of Western Ontario analyzed the drinking habits of Canadians and found that frequent alcohol consumption can lead to binge drinking among all gender and all age groups.
News of the day
Physical Therapists Advocate On Capitol Hill For Access To Rehabilitative Services
Two hundred physical therapists, physical therapist assistants, and students of physical therapy marched on Capitol Hill Tuesday to educate lawmakers about the critical need for patients to have improved access to physical therapy services. The group-members of the American Physical Therapy Association (APTA)-conducted approximately 350 visits with Representatives and Senators.
Sexual Health

As The Market Potential Grows, Developers Press For Keys To Delivering Systemic Drugs Via Inhalation

At a time when the drug industry is striving for patient-friendly delivery methods for new and existing drugs, the growing availability of innovative inhaler device designs is driving interest in pulmonary drug delivery technology and devices as an alternative to oral and parenteral routes of administration. While well-established for treating upper respiratory diseases such as asthma and COPD, companies competing in the inhaled drug delivery sector - major players such as GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim as well as pure-play start-ups - continue to view delivery of systemic drugs via inhalation as a major opportunity. The primary reason for the attraction of systemic pulmonary drug delivery lies in converging and related trends in population demographics and disease incidence. As the median age of the global population continues to increase, conditions and diseases such as menopause, osteoporosis, diabetes, and heart disease, which require long-term therapy, are expected to become significantly more prevalent. This is driving a growing emphasis on drug self-administration for chronic conditions and greater interest in noninvasive drug delivery technology. "The historical landscape for inhaled delivery of systemic drugs is marked by disappointment," explains Paul Brooks, Greystone Associates Senior Analyst. "But advances in drug formulation and inhalation device design are moving this technology approach closer to commercialization." Several of these development-stage drug products have the potential to make a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated. Developments in this sector are the subject of a comprehensive analysis by Greystone Associates, and are contained in a just-released report that analyzes existing and emerging systemic inhalation products, market participants, and key demand and technology factors influencing the commercial market and shaping growth in this sector. More information is available here. Greystone Associates


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):